Asthma drugs counter-regulate interleukin-8 release stimulated by sodium sulfite in an A549 cell line (Q39859892)

15 September 2017

title

Asthma drugs counter-regulate interleukin-8 release stimulated by sodium sulfite in an A549 cell line (English)

1 reference

15 September 2017

0 references

Ya-Fang Yang

1 reference

15 September 2017

Jeng-Yuan Hsu

1 reference

15 September 2017

Lin-Shien Fu

1 reference

15 September 2017

Yueh-Shan Weng

1 reference

15 September 2017

Jao-Jia Chu

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

238-243

1 reference

Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Continued increase in the prevalence of asthma and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Potential bronchoconstrictor stimuli in acid fog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Activation of human epithelial lung a549 cells by the pollutant sodium sulfite: enhancement of neutrophil adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

2. Cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Mucosal inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Effects of sulfur dioxide on the expressions of EGF, EGFR, and COX-2 in airway of asthmatic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Responses of human neutrophils to sulfite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Clinical and biological heterogeneity in children with moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

A cytokine-responsive IκB kinase that activates the transcription factor NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

RU486 (mifepristone): mechanisms of action and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802628508

10.1080/02770900802628508

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference